Filter
402
Text search:
patent
Featured
Recommendations
37
New Publications
101
Language
Document type
No document type
194
Studies & Reports
82
Guidelines
68
Manuals
25
Strategic & Response Plan
14
Fact sheets
10
Training Material
5
Infographics
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
33
Nigeria
31
Global
13
Kenya
9
South Africa
7
Uganda
6
Tanzania
5
Malawi
5
Sierra Leone
4
Liberia
4
Ethiopia
4
Ghana
4
Nepal
4
Ukraine
4
Myanmar / Burma
4
Latin America and the Carribbean
4
Asia
4
Indonesia
3
Western and Central Europe
3
Cameroon
2
Zimbabwe
2
Germany
2
Zambia
2
Rwanda
2
Bangladesh
2
Lesotho
2
East and Southern Africa
2
West and Central Africa
2
Africa
2
Eastern Europe
2
Congo, Democratic Republic of
1
Philippines
1
Pakistan
1
Cambodia
1
Thailand
1
China
1
Mozambique
1
Papua New Guinea
1
Sudan
1
Botswana
1
Venezuela
1
Laos
1
Tajikistan
1
Georgia
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
134
Clinical Guidelines
68
Women & Child Health
28
Public Health
19
Pharmacy & Technologies
19
Key Resources
10
Capacity Building
4
Annual Report MEDBOX
1
Toolboxes
HIV
53
Pharmacy
26
COVID-19
25
AMR
23
TB
19
Caregiver
16
NTDs
13
Global Health Education
9
Malaria
9
NCDs
8
Mental Health
7
Rapid Response
5
Planetary Health
4
Health Financing Toolbox
4
Conflict
3
Refugee
3
Disability
2
Ebola & Marburg
2
Natural Hazards
1
Zika
1
Specific Hazards
1
Social Ethics
1
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries
...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha
...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
Entwicklungen und gegenwärtige Situationen der Covid-19-Impfstoffe
26 July 2021
The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and licensing. GSK retains its No. 1 position, as Novartis moves up into 2nd. Takeda rises furthest in 20
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
Operational Guidelines
Handout presentations in PDF for illustrating lectures
Accessed May 2014
Handout presentations in PDF for illustrating lectures
Accessed May 2014
НА ПУТИ К ЛИКВИДАЦИИ СПИДА
ИЮНЬ 2016 Г.
Clinical Practice Guidelines and Clinical Pathway for Therapy and Management of Heart Disease and Blood Vessels in Indonesia
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб
...
